JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Successful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib

Published online March 31, 2026

Dystrophic epidermolysis bullosa (DEB), caused by mutations in COL7A1 is characterized by the development of blisters, bullae, and eros...

read more
Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review

Published online March 31, 2026

Increasingly, therapeutic advancements in dermatology favor targeted modalities, such as monoclonal antibodies and biologic therapies, ...

read more
Exosome-Based Therapies in Dermatology: A Scoping Review

Published online March 31, 2026

Exosomes are extracellular vesicles released by cells that transfer proteins, lipids, mRNAs, and microRNAs to recipient cells playing a...

read more
An Investigator-Developed Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color

Published online March 31, 2026

Post-inflammatory hyperpigmentation (PIH) is a common acquired condition resulting from an overproduction of melanin or abnormal deposi...

read more
Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations

Published online March 31, 2026

Hyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation, solar lentigines, and drug-induced pigmentation are c...

read more
Eruptive Lentiginosis Within Resolved Psoriasis Plaques: A Case Report and Systematic Review of the Literature

Published online March 30, 2026

Psoriasis is a chronic inflammatory skin condition, affecting approximately three percent of the United States population. While modern...

read more
Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis

Published online March 30, 2026

Acne vulgaris is one of the most common chronic dermatologic conditions globally and often significantly affects quality of life. For m...

read more
Patient Interest in Dermatologists in the United States: A 20-Year Google Trends and Workforce Analysis

Published online March 30, 2026

In recent years, there has been a notable increase in attention to and financial support for dermatology. 1,2 Skin conditions now rank...

read more
Diagnostic Accuracy and Pitfalls of Publicly Available Artificial Intelligence Models for Nail Disorders

Published online March 30, 2026

Nail disorders encompass a broad spectrum of infectious, inflammatory, neoplastic, and traumatic conditions that may present with overl...

read more
The State of Primary Hyperhidrosis: Therapeutic Advancements and National Representation

Published online March 30, 2026

Hyperhidrosis (HH) is defined as excessive sweating beyond the physiologic requirements of thermoregulation. 1 HH is classified as eit...

read more
The Dermoepidermal Junction as the Initiation Point for Reversal of Dermatoporosis

Published online March 30, 2026

Dermatoporosis is a term first coined by Kaya and Saurat in 2007, describing progressive skin thinning, extracellular matrix (ECM) degr...

read more
Objective Measures Needed: Dermatology Program Directors' Perspectives on the USMLE Step 1 Pass/Fail Transition

Published online March 30, 2026

The United States Medical Licensing Examination (USMLE) will stop reporting a 3-digit numerical score and begin reporting a pass/fail o...

read more
Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions

Published online March 26, 2026

Chronic spontaneous urticaria (CSU) is a chronic, debilitating condition characterized by recurrent wheals and/or angioedema. 1 Sympto...

read more
Association Between Topical Ruxolitinib Treatment and Psychiatric Outcomes in Adults With Vitiligo

Published online March 25, 2026

Vitiligo is a chronic autoimmune skin disorder characterized by progressive loss of epidermal melanocytes, resulting in depigmented mac...

read more
Delays in Medical Care Among Skin of Color Melanoma Patients: A Population-Based Study

Published online March 25, 2026

In the United States (US), the incidence of melanoma, the most aggressive and fatal type of skin cancer, has been increasing at an aver...

read more
Rapid Clearance of Lichen Planus With Topical Tapinarof

Published online March 25, 2026

Lichen Planus (LP) is an auto-inflammatory idiopathic condition with unclear etiology, believed to be an auto-reactive response of T-ce...

read more
Beyond Efficacy: 0.6% Selenium Disulfide Shampoo Matches 2% Ketoconazole for Seborrheic Dermatitis with Superior Cosmesis

Published online March 24, 2026

Seborrheic dermatitis (SD) is a chronic, relapsing inflammatory condition. SD affects areas that are rich in sebaceous glands, most com...

read more
Topical Vehicle Design: Educational Intervention Addresses Gap in Dermatology Resident Training

Published online March 13, 2026

Over-the-counter (OTC) products are often used as firstline or adjunctive treatments for many dermatologic conditions. 1,2 Topical for...

read more
The Safety of GLP1 Receptor Agonist Usage in Mohs Micrographic Surgery Patients

Published online March 13, 2026

To the Editor, Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are widely prescribed for type 2 diabetes and, more recently, for obesity man...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

JDD April 2026 Highlights and Editor Picks

| Featured Articles, JDD Highlights, Latest News | No Comments
Curated by the JDD Editors Missed any of our April highlights? April is our immunodermatology issue and is packed with intriguing articles, and you’ll want to start to dive in!…
Journal of Drugs in Dermatology JDD featuring Diagnostic Accuracy and Pitfalls of Publicly Available Artificial Intelligence Models for Nail Disorders

Diagnostic Accuracy and Pitfalls of Publicly Available Artificial Intelligence Models for Nail Disorders

| Featured Articles, Latest News, Nails, Social and Technology | No Comments
AI in Dermatology: Vision Language Models Show Limited Accuracy for Nail Disorders in JDD Study In case you missed it, check out this article from the JDD. A recent study…
Journal of Drugs in Dermatology JDD featuring Objective Measures Needed: Dermatology Program Directors' Perspectives on the USMLE Step 1 Pass/Fail Transition

Objective Measures Needed: Dermatology Program Directors’ Perspectives on the USMLE Step 1 Pass/Fail Transition

| Education, Featured Articles, Latest News | No Comments
JDD Survey: How Dermatology Program Directors Are Responding to Step 1 Pass/Fail Have you read this article from the JDD? A new survey of dermatology residency program directors examine how…
Journal of Drugs in Dermatology JDD Article about Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions

Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions

| Featured Articles, Latest News, Medical Derm | No Comments
Phase 3 data report rapid, clinically meaningful symptom reduction with a tolerable safety profile; early hidradenitis suppurativa signals broaden interest Hot off the pages of JDD, this timely review synthesizes…

Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology

| Featured Articles, Latest News, Podcast Highlights, The JDD Steroid Stewardship Podcast | No Comments
Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology Guest: Dr. Sumayya Ahmad Steroids: beloved (maybe), feared (yup), and, when it comes to the eye, handled with just…

Dermatology Roundup: NPF Clarifies Definition of Psoriasis Disease Severity

| Featured Articles, JDD in the Media, Latest News | No Comments
Survey reveals higher likelihood of reported delays in accessing melanoma care among patients with skin of color The National Psoriasis Foundation (NPF) has a new position statement that clarifies the…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Formulation Foundations: A Peak Behind the Development Curtain

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. David Osborne Finding the right formulation is not always a fun endeavor for the practitioner or patient, and can be the make or break for patient…
Tune In

Follow Us